PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
March 22, 2021 16:01 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical...
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
February 24, 2021 06:04 ET
|
PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
February 04, 2021 13:01 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25,...
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
December 17, 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ：PRAH）今天宣布任命Isaac...
PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA 헬스사이언스, 새롭게 건립하는 Global Center of Excellence for Decentralized Clinical Trial Strategy 총괄할 FDA 고위 인사 영입
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ: PRAH))는 아이잭 로드리게스-차베스(Isaac Rodriguez-Chavez) 박사(공중보건학 석사, 이학 석사)를 과학, 임상 담당 부사장으로 선임한다고 발표했다....
PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) gab heute die Ernennung von Isaac Rodriguez-Chavez, PhD, MHS, MS, zum Senior Vice President, Scientific and...
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...